Skip to content

Pharminent

cropped-ChatGPT-Image-Jun-22-2026-05_46_48-PM.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • Manufacturing
  • AbbVie makes record investment in North Carolina plant
  • Manufacturing

AbbVie makes record investment in North Carolina plant

Pharmaphorum

AbbVie's $100bn programme of facility investments in the US has continued with a new 185-acre campus in Durham, North Carolina.

ManufacturingRead full story

pharminent April 23, 2026 (Last updated: April 23, 2026)

Pharmaphorum

AbbVie’s $100bn programme of facility investments in the US has continued with a new 185-acre campus in Durham, North Carolina.

ManufacturingRead full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: FDA Releases Congressional Justification for FY 2027 Budget, Including Proposal Regarding Interchangeability of Biosimilars
Next: MSD teams up with Google Cloud on agentic AI transformation

Related Stories

  • Manufacturing

pharminent June 17, 2026
  • Manufacturing

Eisai claims UK grant to expand manufacturing site

pharminent June 15, 2026
  • Manufacturing

FDA imposes import alert on Indian plant after inspectors flag GMP failings

pharminent June 12, 2026

You May Have Missed

  • News

pharminent June 22, 2026
sample_feature_2026-06-22
  • News

AbbVie to Acquire Apogee Therapeutics for Nearly $11 Billion in Immunology Bet

pharminent June 22, 2026
  • M&A / Deals

AbbVie climbs post-Allergan M&A peak with Apogee buy

pharminent June 22, 2026
  • M&A / Deals

Lilly bets up to $800M for BioArctic’s brain delivery tech

pharminent June 22, 2026
© 2026 All rights reserved. | ReviewNews by AF themes.